PHIO
Price
$3.00
Change
+$0.54 (+21.95%)
Updated
Jun 6, 12:31 PM (EDT)
Capitalization
11.8M
TPST
Price
$8.28
Change
+$0.34 (+4.28%)
Updated
Jun 6, 02:06 PM (EDT)
Capitalization
29.24M
62 days until earnings call
Interact to see
Advertisement

PHIO vs TPST

Header iconPHIO vs TPST Comparison
Open Charts PHIO vs TPSTBanner chart's image
Phio Pharmaceuticals
Price$3.00
Change+$0.54 (+21.95%)
Volume$2.17K
Capitalization11.8M
Tempest Therapeutics
Price$8.28
Change+$0.34 (+4.28%)
Volume$100
Capitalization29.24M
PHIO vs TPST Comparison Chart
Loading...
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PHIO vs. TPST commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PHIO is a Buy and TPST is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (PHIO: $2.46 vs. TPST: $7.94)
Brand notoriety: PHIO and TPST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PHIO: 155% vs. TPST: 329%
Market capitalization -- PHIO: $11.8M vs. TPST: $29.24M
PHIO [@Biotechnology] is valued at $11.8M. TPST’s [@Biotechnology] market capitalization is $29.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PHIO’s FA Score shows that 0 FA rating(s) are green whileTPST’s FA Score has 0 green FA rating(s).

  • PHIO’s FA Score: 0 green, 5 red.
  • TPST’s FA Score: 0 green, 5 red.
According to our system of comparison, PHIO is a better buy in the long-term than TPST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PHIO’s TA Score shows that 4 TA indicator(s) are bullish while TPST’s TA Score has 3 bullish TA indicator(s).

  • PHIO’s TA Score: 4 bullish, 4 bearish.
  • TPST’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PHIO is a better buy in the short-term than TPST.

Price Growth

PHIO (@Biotechnology) experienced а +20.59% price change this week, while TPST (@Biotechnology) price change was +29.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.55%. For the same industry, the average monthly price growth was +17.24%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

PHIO is expected to report earnings on Mar 31, 2025.

TPST is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+11.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TPST($29.2M) has a higher market cap than PHIO($11.8M). PHIO YTD gains are higher at: 36.667 vs. TPST (-26.810). PHIO has higher annual earnings (EBITDA): -7.41M vs. TPST (-40.14M). PHIO has less debt than TPST: PHIO (0) vs TPST (15.4M). PHIO (0) and TPST (0) have equivalent revenues.
PHIOTPSTPHIO / TPST
Capitalization11.8M29.2M40%
EBITDA-7.41M-40.14M18%
Gain YTD36.667-26.810-137%
P/E Ratio0.01N/A-
Revenue00-
Total Cash5.39MN/A-
Total Debt015.4M-
FUNDAMENTALS RATINGS
PHIO vs TPST: Fundamental Ratings
PHIO
TPST
OUTLOOK RATING
1..100
2918
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9697
PRICE GROWTH RATING
1..100
4965
P/E GROWTH RATING
1..100
6689
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TPST's Valuation (49) in the Pharmaceuticals Major industry is in the same range as PHIO (58) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

TPST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as PHIO (100) in the Biotechnology industry. This means that TPST’s stock grew similarly to PHIO’s over the last 12 months.

PHIO's SMR Rating (96) in the Biotechnology industry is in the same range as TPST (97) in the Pharmaceuticals Major industry. This means that PHIO’s stock grew similarly to TPST’s over the last 12 months.

PHIO's Price Growth Rating (49) in the Biotechnology industry is in the same range as TPST (65) in the Pharmaceuticals Major industry. This means that PHIO’s stock grew similarly to TPST’s over the last 12 months.

PHIO's P/E Growth Rating (66) in the Biotechnology industry is in the same range as TPST (89) in the Pharmaceuticals Major industry. This means that PHIO’s stock grew similarly to TPST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PHIOTPST
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
PHIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TPST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVE13.210.23
+1.77%
Cenovus Energy
ADEA13.310.21
+1.60%
Adeia
STRM5.19N/A
N/A
Streamline Health Solutions Inc
BRDG9.17-0.02
-0.22%
Bridge Investment Group Holdings
KNF92.23-0.65
-0.70%
Knife River Corp